Humanoid Robots Perform First Surgery

July 11, 2026

For the first time, surgeons handed real operating-room work to humanoid robots that removed gallbladders from live pigs, raising big questions about who will control medicine’s future – doctors, tech companies, or distant bureaucrats.

Story Snapshot

Humanoid robots at UC San Diego completed two live gallbladder surgeries on pigs in a world-first preclinical trial.
One procedure used a human-robot team; the second used two humanoid robots working side by side, all teleoperated by surgeons.
The 5-foot-tall robot “Surgie” fits into normal operating rooms, unlike today’s huge, expensive surgical robot consoles.
The tech is years away from human patients, but could reshape access to surgery in rural America and increase corporate and federal control of care.

What Exactly Did These Humanoid Robots Do?

Researchers at the University of California San Diego used teleoperated humanoid robots to perform two minimally invasive gallbladder removals on live pigs during a preclinical trial. Surgeons controlled the robots remotely as the machines retracted tissue, dissected around the liver and gallbladder, and completed the key steps of a standard laparoscopic procedure. One surgery paired a humanoid robot with a human surgeon assistant at the bedside, while the second relied on two humanoid robots working together in the same small space.

The research team describes this as the first in vivo, or “in a living body,” use of a humanoid robotic surgical system for a standard gallbladder removal. Unlike older systems that use custom robot arms fixed to a large cart, the team mounted surgical tools on a general-purpose humanoid body built around the Unitree G1 platform. That platform stands about 5 feet tall and weighs far less than traditional systems, allowing it to move and reach in ways that copy a human assistant at the operating table.

How This Differs From Today’s Robotic Surgery

Most readers have heard of the da Vinci surgical robot, which fills an entire corner of an operating room with a heavy base and multi-armed tower controlled from a large console. Those systems can improve precision but are costly, space-hungry, and often locked into big urban hospitals that can afford them. The humanoid robot from UC San Diego is far lighter and is designed to stand where a human assistant would, using arms that fit into the same cramped space near the patient. That matters for small community hospitals and clinics with tight rooms.

Because the humanoid robot uses a general-purpose body, it does not require a dedicated billion-dollar suite or twelve-hundred-pound console that only specialists can run. Surgeons teleoperate the robot using a control interface, but the machine can in theory be moved between rooms or even facilities like a regular piece of equipment. For families tired of a system that seems to reserve the best care for big-city elites, this kind of flexible design raises the hope that advanced surgery might reach places that Washington and large health systems usually ignore.

How Safe Is It, And How Far Is This From Human Use?

The UC San Diego team is clear: this was a preclinical trial in animals, a proof of concept, not a green light for human patients. Only two surgeries were done, which is enough to show that the setup can work, but far from enough to prove safety or reliability at scale. In at least one surgery, a human bedside surgeon still had to adjust the robot’s arms and help manage the workspace, showing the system is not close to full autonomy.

Regulators at the Food and Drug Administration will demand much larger studies before any humanoid robot touches a human patient. Past research on new surgical robots shows that many “world first” prototypes never reach full approval, even after years of testing. That history should cool down some of the media hype that calls this a medical revolution that will arrive next year. For both conservatives and liberals who already mistrust big tech promises, this is a reminder that the road from lab demo to real patient care is long and often blocked by money, lobbying, and regulation.

Could This Help Rural Patients – Or Just Grow the Medical Machine?

Researchers say one main goal is remote operation, where a skilled surgeon in a major center could control a humanoid robot in a small-town hospital or even an isolated clinic. In theory, that could give rural Americans access to top-level surgical care without traveling hours and missing work. Families who feel left behind by coastal hospitals and academic centers might finally share in the benefits of advanced medicine, instead of watching them on television from afar.

Two humanoid robots just performed a real surgery.

No twelve-hundred-pound console. No dedicated operating suite.

Just a robot, a controller, and a surgeon on the other end.

UC San Diego proved it works.

One team paired a robot with a human surgeon for a gallbladder…

— NextInSurgery (@nextinsurgery) July 11, 2026

At the same time, teleoperated humanoid surgery could tighten control of health care in the hands of large hospital chains, device makers, and federal regulators. If only a few approved platforms and big-city surgeons can legally run these systems, community doctors may lose more independence. Both the right and the left already worry that unelected experts and corporate boards make too many decisions about care. This technology could either break that pattern by spreading access or deepen it by centralizing power.

Why The Hype – And What Should Citizens Watch?

News outlets and social media posts have rushed to brand the UC San Diego work as “historic,” using phrases like “world’s first live animal surgeries” and “humanoid robots perform live surgery.” That kind of hype grabs clicks but rarely explains the limits, like the tiny sample size, the lack of human trials, or the need for years of follow-up studies. The robot is even referred to by different names, “Surgie,” “Surge,” or “Sergei,” which shows how quickly details get fuzzy once a story enters the online rumor mill.

For citizens on both sides of the aisle, this event is a case study in how high-tech medicine, media, and government interact. Universities gain prestige and future licensing deals from splashy “firsts.” Tech and device companies see new markets. Regulators must decide how fast to move without turning patients into test subjects. Meanwhile, everyday Americans simply want safe, affordable surgery close to home. Watching how this humanoid robot project moves from pig trials to policy fights will reveal a lot about who the health system really serves.